Published in Am J Gastroenterol on November 01, 1999
Improved prognosis of cirrhosis patients with esophageal varices and thrombocytopenia treated by endoscopic variceal ligation plus partial splenic embolization. Dig Dis Sci (2006) 1.50
Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins. BMC Gastroenterol (2009) 1.19
Right liver lobe/albumin ratio: contribution to non-invasive assessment of portal hypertension. World J Gastroenterol (2007) 1.07
Platelet count/bipolar spleen diameter ratio for the prediction of esophageal varices: The special Egyptian situation: Noninvasive prediction of esophageal varices. Hepat Mon (2011) 1.06
Predictors of esophageal varices in patients with HBV-related cirrhosis: a retrospective study. BMC Gastroenterol (2009) 1.04
Noninvasive prediction of large esophageal varices in chronic liver disease patients. Saudi J Gastroenterol (2010) 1.03
External validation of the platelet count/spleen diameter ratio for the diagnosis of esophageal varices in hepatitis C virus-related cirrhosis. Dig Dis Sci (2008) 1.02
Hepatocellular carcinoma in cirrhotic patients with portal hypertension: is liver resection always contraindicated? World J Gastroenterol (2011) 0.94
Variceal Hemorrhage. Curr Treat Options Gastroenterol (2002) 0.93
Prediction of esophageal varices in patients with cirrhosis: usefulness of three-dimensional MR elastography with echo-planar imaging technique. Radiology (2014) 0.92
Platelet count to spleen diameter ratio for the diagnosis of esophageal varices: Is it feasible? Can J Gastroenterol (2008) 0.90
Clinical predictors of large esophageal varices: how accurate are they? Am J Gastroenterol (1999) 0.89
Non-invasive predictors of esophageal varices. Saudi J Gastroenterol (2011) 0.88
Clinical characteristics of patients with hepatocellular carcinoma in a middle eastern population. Hepat Mon (2013) 0.86
Platelet count/spleen diameter ratio to predict esophageal varices in Mexican patients with hepatic cirrhosis. World J Gastroenterol (2014) 0.85
A clinical predictor of varices and portal hypertensive gastropathy in patients with chronic liver disease. Clin Mol Hepatol (2012) 0.84
Prediction of large esophageal varices in cirrhotic patients using classification and regression tree analysis. Clinics (Sao Paulo) (2011) 0.84
Portal hemodynamics as predictors of high risk esophageal varices in cirrhotic patients. World J Gastroenterol (2008) 0.83
Prediction of oesophageal varices with platelet count/spleen diameter ratio or platelets alone. Gut (2004) 0.82
Clinical predictors of large esophagogastric varices in patients with hepatocellular carcinoma. Dig Dis Sci (2002) 0.81
The predictors of the presence of varices in patients with primary sclerosing cholangitis. Hepatology (2010) 0.80
Usefulness of Noninvasive Predictors of Oesophageal Varices in Black African Cirrhotic Patients in Côte d'Ivoire (West Africa). Gastroenterol Res Pract (2012) 0.79
Practice patterns in screening for varices: an American survey. Dig Liver Dis (2009) 0.78
Current Management of Esophageal Varices. Curr Treat Options Gastroenterol (2003) 0.76
Nitric oxide levels in chronic liver disease patients with and without oesophageal varices. Hepatol Int (2008) 0.76
Non-invasive prediction of esophageal varices: is it possible? Saudi J Gastroenterol (2011) 0.76
Noninvasive predictors of large varices in patients hospitalized with gastroesophageal variceal hemorrhage. Hepatol Int (2007) 0.75
Towards noninvasive detection of oesophageal varices. Int J Hepatol (2012) 0.75
Portal vein Doppler: a tool for non-invasive prediction of esophageal varices in cirrhosis. J Clin Diagn Res (2014) 0.75
The Role of Spleen Stiffness in Determining the Severity and Bleeding Risk of Esophageal Varices in Cirrhotic Patients. Medicine (Baltimore) (2015) 0.75
Post-gastrectomy spleen enlargement and esophageal varices: distal vs total gastrectomy. World J Gastroenterol (2010) 0.75
Non-invasive Diagnosis of Oesophageal Varices Using Systemic Haemodynamic Measurements by Finometry: Comparison with Other Non-invasive Predictive Scores. J Clin Exp Hepatol (2016) 0.75
DNA recognition by GAL4: structure of a protein-DNA complex. Nature (1992) 5.60
Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates. The Enteric Opportunistic Infections Working Group. N Engl J Med (1992) 4.23
A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat Med (1999) 4.20
The association between beta-agonist use and death from asthma. A meta-analytic integration of case-control studies. JAMA (1993) 3.09
How different eukaryotic transcriptional activators can cooperate promiscuously. Nature (1990) 2.91
Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut (1999) 2.44
Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med (1994) 2.44
Polymerase II promoter activation: closed complex formation and ATP-driven start site opening. Science (1992) 2.42
The rational clinical examination. Does this patient have strep throat? JAMA (2000) 2.30
A general mechanism for transcriptional synergy by eukaryotic activators. Nature (1995) 2.29
Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med (2000) 2.27
5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons [see comment]. Gastroenterology (1996) 2.24
The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States. J Gen Virol (1998) 2.22
Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology (2000) 2.21
Use of the alveolar-arterial oxygen gradient in the diagnosis of pulmonary embolism. Am J Med (1994) 2.16
Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab (2000) 2.09
Evaluation of the Winthrop-University Hospital criteria to identify Legionella pneumonia. Chest (2001) 2.08
Activation of yeast polymerase II transcription by herpesvirus VP16 and GAL4 derivatives in vitro. Mol Cell Biol (1989) 2.06
Expression of enhanced levels of small RNA polymerase III transcripts encoded by the B2 repeats in simian virus 40-transformed mouse cells. Nature (1985) 1.98
Apolipoproteins in human cerebrospinal fluid. Proc Natl Acad Sci U S A (1979) 1.96
Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Br J Radiol (2003) 1.92
The acidic activator GAL4-AH can stimulate polymerase II transcription by promoting assembly of a closed complex requiring TFIID and TFIIA. Genes Dev (1992) 1.89
Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc Natl Acad Sci U S A (2001) 1.85
Recruitment of the putative transcription-repair coupling factor CSB/ERCC6 to RNA polymerase II elongation complexes. Mol Cell Biol (1997) 1.83
Meta-analysis and cost comparison of polyethylene glycol lavage versus sodium phosphate for colonoscopy preparation. Gastrointest Endosc (1998) 1.82
The effects of intracuff lidocaine on endotracheal-tube-induced emergence phenomena after general anesthesia. Anesth Analg (2000) 1.77
The requirement for the basal transcription factor IIE is determined by the helical stability of promoter DNA. EMBO J (1995) 1.77
Assembly of the isomerized TFIIA--TFIID--TATA ternary complex is necessary and sufficient for gene activation. Genes Dev (1996) 1.76
Choice of long-term strategy for the management of patients with severe esophagitis: a cost-utility analysis. Gastroenterology (1997) 1.75
Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial. J Clin Oncol (2001) 1.73
Occult hepatitis B virus infection: a covert operation. J Viral Hepat (2009) 1.69
Yeast HMG proteins NHP6A/B potentiate promoter-specific transcriptional activation in vivo and assembly of preinitiation complexes in vitro. Genes Dev (1996) 1.66
Meta-analysis: randomized controlled trials of 4-L polyethylene glycol and sodium phosphate solution as bowel preparation for colonoscopy. Aliment Pharmacol Ther (2010) 1.65
Anthropogenic impacts on the distribution and biodiversity of benthic macroinvertebrates and water quality of the Langat River, Peninsular Malaysia. Ecotoxicol Environ Saf (2005) 1.61
Upper gastrointestinal bleeding in patients with chronic renal failure: role of vascular ectasia. Am J Gastroenterol (1996) 1.59
Clinical reactogenicity of intradermal bacille Calmette-Guérin vaccination. Clin Infect Dis (1999) 1.59
Patients willing to try colonoscopy without sedation: associated clinical factors and results of a randomized controlled trial. Gastrointest Endosc (1999) 1.59
Do all patients with abnormal intraoperative cholangiogram merit endoscopic retrograde cholangiopancreatography? Surg Endosc (2006) 1.54
Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation? Liver Transpl Surg (1998) 1.54
Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR). Aliment Pharmacol Ther (2012) 1.51
A synergistic increase in potency of a multimerized VP16 transcriptional activation domain. EMBO J (1992) 1.51
The alteration of serum potassium level during sample transit. Practitioner (1989) 1.51
Blood urea nitrogen to creatinine concentration in gastrointestinal bleeding: a reappraisal. Am J Gastroenterol (1997) 1.50
The effects of midodrine on the natriuretic response to furosemide in cirrhotics with ascites. Aliment Pharmacol Ther (2010) 1.49
Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C. Hepatology (2001) 1.49
Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. Oncogene (2001) 1.48
Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage: a cost-effectiveness analysis. Aliment Pharmacol Ther (2007) 1.48
Hepatic hydrothorax. Semin Liver Dis (1997) 1.48
Patient response to laryngeal mask insertion after induction of anaesthesia with propofol or thiopentone. Can J Anaesth (1993) 1.47
Mechanism for specificity by HMG-1 in enhanceosome assembly. Mol Cell Biol (2000) 1.44
Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Am J Gastroenterol (1999) 1.43
Reduction of severity of pruritus after elective caesarean section under spinal anaesthesia with subarachnoid morphine: a randomised comparison of prophylactic granisetron and ondansetron. Int J Obstet Anesth (2009) 1.41
Prolongation of prothrombin time with ivermectin. Lancet (1988) 1.41
High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis. Clin Exp Immunol (1998) 1.40
A quantitative assessment of the risks and cost savings of forgoing histologic examination of diminutive polyps. Endoscopy (2011) 1.39
[Effort phlebitis of the upper limb. Report of 5 cases]. J Mal Vasc (2001) 1.39
Recommendations regarding total daily fluoride intake for Canadians. J Can Dent Assoc (1994) 1.39
Prolonged survival among women with BRCA germline mutations and advanced endometrial cancer: a case series. Int J Gynecol Cancer (2007) 1.39
Placement and replacement of restorations in a military population. J Can Dent Assoc (1991) 1.38
Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis. Aliment Pharmacol Ther (2007) 1.38
Some reasons for the lack of progress in the treatment of acute myelogenous leukemia: a review of three consecutive trials of the treatment of poor prognosis patients. Leuk Res (1991) 1.38
Direct transhepatic measurement of portal vein pressure using a thin needle. Comparison with wedged hepatic vein pressure. Gastroenterology (1977) 1.38
Declining CD4+ T-lymphocyte counts are associated with increased risk of enteric parasitosis and chronic diarrhea: results of a 3-year longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.36
Brucella abortus genes identified following constitutive growth and macrophage infection. Infect Immun (2001) 1.34
Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors. Gene Ther (2001) 1.33
The ZEBRA activation domain: modular organization and mechanism of action. Mol Cell Biol (1993) 1.33
Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer. J Biol Chem (1999) 1.32
A heteroduplex template circumvents the energetic requirement for ATP during activated transcription by RNA polymerase II. J Biol Chem (1994) 1.31
Cocaine-associated ischemic colitis. South Med J (2000) 1.30
Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer. Cancer Res (2000) 1.30
Arachnoid cyst and associated subdural hematoma. Observations on conventional roentgenographic and computerized tomographic diagnosis. Arch Neurol (1978) 1.27
Short-term in vitro culture and molecular analysis of the microsporidian, Enterocytozoon bieneusi. J Eukaryot Microbiol (1995) 1.27
Modulating the potency of an activator in a yeast in vitro transcription system. Mol Cell Biol (1994) 1.27
Characterization of human immunodeficiency virus type 1 strains recovered from the bowel of infected individuals. Virology (1991) 1.26
Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease. Gastroenterology (1979) 1.26
The role of activators in assembly of RNA polymerase II transcription complexes. Curr Opin Genet Dev (1994) 1.25
Endocytosis and vesicle trafficking during tip growth of root hairs. Protoplasma (2005) 1.24
Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. J Pain Symptom Manage (1993) 1.22
Graphical search for two-stage designs for phase II clinical trials. Control Clin Trials (2001) 1.20
Kala-azar in a high transmission focus: an ethnic and geographic dimension. Am J Trop Med Hyg (1999) 1.19
Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology (2000) 1.18
Changes in performance, muscle metabolites, enzymes and fibre types after short sprint training. Eur J Appl Physiol Occup Physiol (1998) 1.18
Selective shunt in the management of variceal bleeding in the era of liver transplantation. Ann Surg (1992) 1.18
Acetaminophen-induced hepatic necrosis and renal failure. JAMA (1971) 1.18
Portal and systemic bacteraemia and endotoxaemia in liver disease. Gut (1978) 1.17
Correlation between exchange bias and pinned interfacial spins. Phys Rev Lett (2003) 1.16
Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis. Clin Exp Immunol (1994) 1.16
Effect of food and food composition on alcohol elimination rates in healthy men and women. J Clin Pharmacol (2001) 1.15
The changing etiology of chronic diarrhea in HIV-infected patients with CD4 cell counts less than 200 cells/mm3. Am J Gastroenterol (2000) 1.14
Suspected sphincter of Oddi dysfunction type II: empirical biliary sphincterotomy or manometry-guided therapy? Endoscopy (2004) 1.14
Markers of low level arsenic exposure for evaluating human cancer risks in a US population. Int J Occup Med Environ Health (2001) 1.13
Human glutathione S-transferases. Semin Liver Dis (1998) 1.13
Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol (1994) 1.10
Prospective endoscopic evaluation for gastrointestinal graft-versus-host disease: determination of the best diagnostic approach. Bone Marrow Transplant (2006) 1.10
Structural, functional and hybridization studies of the glutathione S-transferases of rat liver. Biochem Pharmacol (1983) 1.10
Compensatory energetic relationships between upstream activators and the RNA polymerase II general transcription machinery. J Biol Chem (1998) 1.09
Localization of a portion of the active site of two rat liver glutathione S-transferases using a photoaffinity label. J Biol Chem (1989) 1.08
Diagnosis of gastrointestinal graft-versus-host disease. Am J Gastroenterol (2000) 1.08